SecBot SecBot
SECBOTREPLAY Home › Report › VIR

VIR · Vir Biotechnology appointed CEO Marianne De Backer to the additional…

Vir Biotechnology, Inc. · 8-K filed Mar 4, 2026 at 16:02 ET

At the news

NEUTRALIMPACT 3/10

8-K filed Mar 4, 2026 at 16:02 ET

Vir Biotechnology appointed CEO Marianne De Backer to the additional role of President. This is an internal leadership expansion with no immediate financial impact or executive departure.

  • Marianne De Backer, current CEO and principal executive officer, was appointed to the additional role of President on March 4, 2026
  • No executive departures were reported
  • No compensation details were disclosed in the filing
  • The appointment reflects a consolidation of leadership roles under the existing CEO

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access